such as Athersys (ATHX) and Mesoblast (MESO). Gern Corporation had an earning conference call today. The company's stock as a result finished up over 28% in today's trading session. Closing the day at $4.34, this is the highest the …
NBC293mon
Athersys (NASDAQ:ATHX) surged in early trading after the biotechnology company said it will receive an initial license fee of $15mln. Shares rose as much as 11.2% as of 8:13 a.m. in New York. The stock closed up 21.4% at $1.25 on …
In such a scenario, we advise investors to forget Gilead, a Zacks Rank #4 (Sell) stock, and invest in some other small cap biotech stocks (market capitalization ... Headquartered in Cleveland, Ohio, Athersys, Inc. ATHX is developing its …
The stock does have a nice history of beating estimates though, while it has a Zacks Rank #2 (Buy) a positive earnings ESP which suggests a beat. And last but not least, Procter & Gamble (PG) is also up this week, reporting on the …
Here are today’s five biggest gaining stocks at closing: Comstock Holding Companies Inc. (NASDAQ: CHCI) is up 59.8% at $1.87. Redhill Biopharma Ltd. (NASDAQ: RDHL) is up 41.3% at $11.95. ... Read Full Story »
Note that the year-to-date share price movement of Roche shows that the stock has underperformed the Zacks classified ... sector include Anika Therapeutics ANIK, Athersys, Inc. ATHX and Arbutus Biopharma Corp. ABUS. Anika and …
BioLineRx ( BLRX) has made regulatory submissions to the Finnish National Supervisory Authority for Welfare and Health (Valvira) for initiating a phase I/II study on the company's candidate BL-7010. The candidate is being developed for the …